Synovics Pharmaceuticals, Inc.

Synovics Pharmaceuticals, Inc.

SYVC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.98K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Synovics Pharmaceuticals, Inc.Synovics Pharmaceuticals, Inc.0-653%--5.9

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2,983.00
Enterprise Value$4.41 Million
Earnings per Share$-0.17
Beta-0.28
Outstanding Shares29,885,196

Return

Return on Equity652.52%ROE
Return on Assets-26.88%
Return on Invested Capital-157.51%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue0.23
Enterprise Value to EBIT-2.3
Enterprise Value to Net Income-1
Total Debt to Enterprise1.03
Debt to Equity-5.87Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Synovics Pharmaceuticals, Inc.

155 employees
CEO: Christopher J. Flynn

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the Un...